MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-TN-08-0005573
Tigma Pharma Private Limited - chemicals in Chennai, Tamil Nadu, India. Directors, charges & compliance details.
Revenue · FY 2022
₹2.6 Lakh
▲ 30% YoY
Net loss · FY 2022
₹13,398
Net margin -5.2%
EBITDA · FY 2022
-₹13,398
EBITDA margin -5.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10,000
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
3
As per MCA filings
Last financials
Mar 2022
Balance sheet date
About Tigma Pharma Private Limited
Data last updated:
Tigma Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 30 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24230TN2020PTC136067.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10,000. It is led by directors including Vanita Ashokkumar Naidu and Archana Pattnaik.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at B1 B Block Quanta Chrome No – 1 Ramachandra Road Nehru Nagar Chrompet, Chennai, Tamil Nadu, India – 600044.
As per the financials filed for FY 2022, the company reported a revenue of ₹2.6 Lakh, a growth of 30% compared to the previous year. For the same year it recorded a net loss of ₹13,398 (net margin -5.2%) and EBITDA of -₹13,398 (EBITDA margin -5.2%).
Tigma Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-08-0005573). For more details, the company can be reached via its website tigmapharma.com.
Company Details of Tigma Pharma Private Limited
CIN U24230TN2020PTC136067
Registration Number 136067
Incorporation Date 30 June 2020
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2022
Date of Balance Sheet 31 March 2022
MSME Classification Micro
Udyam Registration UDYAM-TN-08-0005573
Recognitions & Rankings of Tigma Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressB1 B Block Quanta Chrome No – 1 Ramachandra Road Nehru Nagar Chrompet, Chennai, Tamil Nadu, India – 600044
- IndustryChemicals, Manufacturing, Other Chemical Product
Comprehensive company report
Tigma Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Tigma Pharma Private Limited
The main business activity of Tigma Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Tigma Pharma Private Limited FY 2022 filings available
Tigma Pharma Private Limited reported revenue of ₹2.6 Lakh (up 30% YoY) for FY 2022.
Revenue · FY 2022
₹2.6 Lakh ▲ 30%
Net loss · FY 2022
₹13,398 margin -5.2%
EBITDA · FY 2022
-₹13,398 margin -5.2%
Compounded Annual Growth Rate (CAGR) of Tigma Pharma Private Limited
Revenue CAGR growth
1 year
▲ 30%
Revenue rose 30% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Tigma Pharma Private Limited
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | -₹13,398 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹13,398 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Tigma Pharma Private Limited
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -5.2% | •••• |
| Net Profit Margin | -5.2% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Tigma Pharma are in the company report.
Premium access
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Tigma Pharma Private Limited
Tigma Pharma has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vanita Ashokkumar Naidu Also directs: Kavm Grains Private Limited | Director | 30 Jun 2020 | 6 Years 3 Months | Current |
| Archana Pattnaik | Director | 08 Feb 2021 | 5 Years 8 Months | Current |
| Ankith Katageri | Director | 30 Jun 2020 | 6 Years 3 Months | Current |
Peer Comparison of Tigma Pharma Private Limited
Tigma Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Classic Prime Home Care Private Limited | ₹2.62 Lakh (FY 2025) | •••• | •••• | 0.0% | •••• | Bhilwara, Rajasthan, India |
| Suko Organics Private Limited | ₹2.61 Lakh (FY 2016) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Epicure Bio-Med Private Limited | ₹2.61 Lakh (FY 2016) | •••• | •••• | -44.0% | •••• | Hyderabad, Telangana, India |
| Rootback Nutra Private Limited | ₹2.6 Lakh (FY 2025) | •••• | •••• | -82.0% | •••• | Chandigarh, India |
| Yamuna Pharmaceuticals Private Limited | ₹2.6 Lakh (FY 2025) | •••• | •••• | -46.0% | •••• | Jagadhri, Haryana, India |
| Tigma Pharma Private Limited this company | ₹2.6 Lakh (FY 2022) | •••• | •••• | 30.0% | •••• | Chennai, Tamil Nadu, India |
| Seaneas India Private Limited | ₹2.6 Lakh (FY 2025) | •••• | •••• | 109.0% | •••• | Bangalore, Karnataka, India |
| Synamed Pharmaceuticals (India) Private Limited | ₹2.59 Lakh (FY 2021) | •••• | •••• | -5.0% | •••• | Mumbai, Maharashtra, India |
| Dhumketu Chemical Industries Private Limited | ₹2.58 Lakh (FY 2023) | •••• | •••• | 6.0% | •••• | Warangal, Telangana, India |
| Om S Intercontinental Private Limited | ₹2.58 Lakh (FY 2024) | •••• | •••• | -12.0% | •••• | Indore, Madhya Pradesh, India |
| Lexico Paints Private Limited | ₹2.57 Lakh (FY 2020) | •••• | •••• | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Tigma Pharma by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Tigma Pharma Private Limited
Tigma Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Tigma Pharma Private Limited
Employment history and EPFO contributions of people linked to Tigma Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Tigma Pharma Private Limited
Tigma Pharma Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Archana Pattnaik was appointed as Director on 08 Feb 2021.
AGM
Tigma Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Filing
Tigma Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Chennai.
Appointed
Archana Pattnaik was appointed as Director.
Appointed
Ankith Katageri was appointed as Director.
Appointed
Vanita Ashokkumar Naidu was appointed as Director.
Incorporation
30 Jun 2020
Tigma Pharma Private Limited was registered on 30 Jun 2020 with Roc Chennai & aged 6 years 3 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Tigma Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Tigma Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Tigma Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Tigma Pharma Private Limited
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Tigma Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tigma Pharma Private Limited
Tigma Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 30 June 2020 (6+ years old) and is registered under CIN U24230TN2020PTC136067.
Tigma Pharma reported revenue of ₹2.6 Lakh for FY 2022 (up 30% YoY).
Tigma Pharma has 3 current directors:
- Vanita Ashokkumar Naidu - Director
- Archana Pattnaik - Director
- Ankith Katageri - Director
Tigma Pharma reported a net loss of ₹13,398 (net margin -5.2%) and EBITDA of -₹13,398 (EBITDA margin -5.2%) for FY 2022, as per its filed financial statements.
The CIN (Corporate Identification Number) of Tigma Pharma is U24230TN2020PTC136067. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tigma Pharma was incorporated on 30 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Tigma Pharma by revenue are Classic Prime Home Care Private Limited, Suko Organics Private Limited, Epicure Bio-Med Private Limited, Rootback Nutra Private Limited, Yamuna Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Archana Pattnaik was appointed as Director on 08 Feb 2021. Ankith Katageri was appointed as Director on 30 Jun 2020. Vanita Ashokkumar Naidu was appointed as Director on 30 Jun 2020.
Yes, Tigma Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-08-0005573).
Tigma Pharma can be reached through the website tigmapharma.com. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of Tigma Pharma is at B1 B Block Quanta Chrome No – 1 Ramachandra Road Nehru Nagar Chrompet, Chennai, Tamil Nadu, India – 600044.